The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary (1°) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance).
 
Alan P. Venook
Honoraria - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences; Merrimack
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Serono (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Merck Serono; Merrimack; Roche; Taiho Pharmaceutical
 
Fang-Shu Ou
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Omar Kabbarah
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Research Funding - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Dna Farber Cancer Institute; Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Xueping Qu
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Research Funding - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Donna Niedzwiecki
No Relationships to Disclose
 
Tyler Zemla
No Relationships to Disclose
 
Richard M. Goldberg
Honoraria - Baxter; Biothera; Forty Seven; Immunocare Therapies; Immunovative Therapies; kanghong Pharma; Merck; Merrimack; Momenta Pharmaceuticals; Novo Nordisk; Pfizer; Sirtex Medical; Taiho Pharmaceutical; Targovax
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Baxter; Merck KGaA; Sanofi
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
 
Bert H. O'Neil
Consulting or Advisory Role - Amgen; Bayer; Genentech/Roche; Lilly/ImClone
Travel, Accommodations, Expenses - Merck KGaA
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Precision Biologics (Inst)
 
Robert J. Mayer
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - CASI Pharmaceuticals
 
Monica M. Bertagnolli
No Relationships to Disclose
 
Charles David Blanke
No Relationships to Disclose
 
Federico Innocenti
Patents, Royalties, Other Intellectual Property - Royalties from the Mayo Foundation on the UGT1A1 testing